Milestone Asset Management, Llc
Source: SEC Form 13F · as of Mar 2026Milestone Asset Management, Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $32.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$32.1M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 123,709 | $7.5M |
| ABBVAbbVie Inc. | 26,258 | $5.7M |
| LLYELI LILLY & Co | 5,099 | $4.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,128 | $2.5M |
| LNTHLantheus Holdings, Inc. | 19,033 | $1.4M |
| PCRXPacira BioSciences, Inc. | 60,058 | $1.4M |
| CAHCardinal Health Inc. | 5,873 | $1.2M |
| PBHPrestige Consumer Healthcare Inc. | 20,735 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 8,166 | $1.1M |
| MRKMerck & Co., Inc. | 9,228 | $1.1M |
| CORCencora Inc. | 3,415 | $1.1M |
| PFEPFIZER INC | 38,171 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,975 | $882K |
| AMGNAMGEN INC | 2,290 | $806K |
| CRBUCaribou Biosciences, Inc. | 162,076 | $308K |
| ACHAccendra Health Inc. | 12,000 | $27K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.